South African Government Conference Reveals Views On Draft Copyright Bill

MacDonald Netshitenzhe, Chief Director of Policy and Legislation at DTI

JOHANNESBURG, SOUTH AFRICA — Stakeholders from various positions of influence in the realm of intellectual property – including government – put a fine tooth comb through the South African Copyright Amendment Bill at a consultative conference called by the Department of Trade and Industry yesterday.

WIPO Launches Development Agenda Program In Uganda

Delegates at the launch of the WIPO program in Uganda

KAMPALA, UGANDA – The World Intellectual Property Organization (WIPO) has launched a Development Agenda program in Uganda, aimed at building capacity in the use of appropriate technology, specific technical and scientific information to address development challenges in the country.

IP Experts Kick Off UC Berkeley Innovation Centre With Calls For Change

Berkeley Haas-eastentrance-280

BERKELEY, CALIFORNIA — “There’s only one thing we’re good at in this nation, and that’s innovation,” Tusher Center Director and Professor David Teece said recently in setting the tone for a day of discussions inspired by the launch of the new center at the University of California at Berkeley.

NGOs Call Out Switzerland For Pressuring Colombia On Compulsory Licences; Switzerland Replies

Glivec

Civil society groups are calling on the Swiss government to refrain from putting pressure on developing countries wishing to manufacture generic medicines without the consent of the patent holder. The groups allege that the Swiss government tried to unduly influence Colombia to not take such a step, though it is permitted by international trade rules.

The Swiss government, for its part, says it participated in a public consultation in Colombia and merely underlined that negotiations between governments and original manufacturers are a better way to go than a compulsory licence.

USPTO Proposes New PTAB Trial Rules

Bernard Knight

This week the United States Patent and Trademark Office (USPTO) published a proposed rule to amend the existing rules of practice for inter partes review, post-grant review, the transitional program for covered business method patents and derivation proceedings that implemented provisions of the Leahy-Smith America Invents Act (AIA).

Trade Secrets: The ‘Reasonable Steps’ Requirement

CREATe_org-Trade-Secrets-Reasonable-Steps-7_15_15_Final_cover

Trade secret theft is a top risk for companies today. When the worst does happen and trade secrets are compromised, companies must prove that reasonable steps have been taken to protect a company’s crown jewels. But determining what “reasonable steps” are can be challenging. Governments have been vague about the term’s definition; and laws and legislation continue to evolve on this issue. However, court actions do provide insight on the ‘reasonable steps requirement’ and point to the need for companies to embed trade secret protection into business operations to qualify as legal protection, writes Pamela Passman.

Conference Looks At Public Interest In South Africa’s Draft Copyright Bill

The Conference on Internet Rights, Cultural Development and Balancing Features in South African Copyright Reform

PRETORIA, SOUTH AFRICA – A conference here this week elicited a robust debate amongst intellectual property stakeholders in South Africa about the objectives of the far-reaching draft Copyright Amendment Bill.

IP-Watch Seeks Part-Time Fundraising/Outreach Expert

ipw-logo-squre

Intellectual Property Watch is seeking a dynamic person to help expand our fundraising and outreach activities.

WHO Heralds Breakthrough On Ebola Vaccine: “Turning Point In History Of Health R&D”

ebola vaccine

The World Health Organization announced today that a vaccine preventing Ebola has proved efficacious in Ebola-stricken Guinea, hailing it as a “turning point in the history of health R&D.”

Medicines Patent Pool At 5 Years: Promises Kept, Changes Ahead – An Interview With Greg Perry

MPPF-LOGO_2_COLORS

The Medicines Patent Pool in Geneva is celebrating five years of existence this month. MPP Executive Director Greg Perry sat down with Intellectual Property Watch Catherine Saez to describe progress made since its inception, the success of its licensing agreement model, and plans for the future, including a possible extension to other diseases such as tuberculosis and hepatitis C.